Literature DB >> 16199221

Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma.

Eisuke Yasuda1, Takashi Kumada, Shinji Takai, Akira Ishisaki, Takahiro Noda, Rie Matsushima-Nishiwaki, Naoki Yoshimi, Kanefusa Kato, Hidenori Toyoda, Yuji Kaneoka, Akihiro Yamaguchi, Osamu Kozawa.   

Abstract

Heat shock protein 27 (HSP27) is expressed at high levels in human hepatocellular carcinoma (HCC). We examined correlations of total HSP27 and serine phosphorylated (Ser-15, Ser-78, and Ser-82) HSP27 levels in HCC tissues with clinical and pathologic characteristics in 48 resected HCC specimens. The levels of total and Ser-phosphorylated HSP27 were evaluated by Western blot analysis. Immunohistochemical analysis of HSP27 expression was also performed on some samples. Phosphorylation of HSP27 was detected in all 48 HCC tissues. Levels of phosphorylated HSP27 were correlated inversely with tumor size, microvascular invasion of HCC, and tumor stage by TNM classification. In contrast, only microvascular invasion showed an inverse correlation with total HSP27 levels. The decrease in phosphorylated HSP27 in progressed HCC was also observed by immunohistochemistry. Levels of phosphorylated HSP27 gradually decreased in parallel with HCC progression. Our findings suggest that phosphorylated HSP27 may have a suppressive role in progression of human HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199221     DOI: 10.1016/j.bbrc.2005.08.273

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Comparing signaling networks between normal and transformed hepatocytes using discrete logical models.

Authors:  Julio Saez-Rodriguez; Leonidas G Alexopoulos; Mingsheng Zhang; Melody K Morris; Douglas A Lauffenburger; Peter K Sorger
Journal:  Cancer Res       Date:  2011-07-08       Impact factor: 12.701

Review 2.  New insights in hepatocellular carcinoma: from bench to bedside.

Authors:  Samuele De Minicis; Marco Marzioni; Antonio Benedetti; Gianluca Svegliati-Baroni
Journal:  Ann Transl Med       Date:  2013-07

3.  Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies.

Authors:  James P Hamilton
Journal:  Epigenomics       Date:  2010-04-01       Impact factor: 4.778

Review 4.  Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology.

Authors:  Sergiy Kostenko; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2009-07-11       Impact factor: 9.261

5.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.

Authors:  Toshiharu Sakurai; Guobin He; Atsushi Matsuzawa; Guann-Yi Yu; Shin Maeda; Gary Hardiman; Michael Karin
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

6.  Maternal Smoking Dysregulates Protein Expression in Second Trimester Human Fetal Livers in a Sex-Specific Manner.

Authors:  Panagiotis Filis; Nalin Nagrath; Margaret Fraser; David C Hay; John P Iredale; Peter O'Shaughnessy; Paul A Fowler
Journal:  J Clin Endocrinol Metab       Date:  2015-03-24       Impact factor: 5.958

7.  Therapeutics Based on microRNA: A New Approach for Liver Cancer.

Authors:  G Zhang; Q Wang; R Xu
Journal:  Curr Genomics       Date:  2010-08       Impact factor: 2.236

8.  Hepatocellular carcinoma: a systems biology perspective.

Authors:  Lorenza A D'Alessandro; René Meyer; Ursula Klingmüller
Journal:  Front Physiol       Date:  2013-02-25       Impact factor: 4.566

9.  Phosphorylation of Ser78 of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer.

Authors:  Daohai Zhang; Lee Lee Wong; Evelyn S C Koay
Journal:  Mol Cancer       Date:  2007-08-14       Impact factor: 27.401

10.  Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action.

Authors:  M Michailidou; I N Melas; D E Messinis; S Klamt; L G Alexopoulos; F N Kolisis; H Loutrari
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.